Annual CFO
-$12.89 M
-$722.00 K-5.93%
December 31, 2021
Summary
- As of February 10, 2025, SYN annual cash flow from operations is -$12.89 million, with the most recent change of -$722.00 thousand (-5.93%) on December 31, 2021.
- During the last 3 years, SYN annual CFO has risen by +$4.39 million (+25.40%).
Performance
SYN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFO
-$4.36 M
+$546.00 K+11.14%
June 30, 2022
Summary
- As of February 10, 2025, SYN quarterly cash flow from operations is -$4.36 million, with the most recent change of +$546.00 thousand (+11.14%) on June 30, 2022.
- Over the past year, SYN quarterly CFO has dropped by -$1.76 million (-67.80%).
Performance
SYN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
-$16.22 M
-$1.76 M-12.17%
June 30, 2022
Summary
- As of February 10, 2025, SYN TTM cash flow from operations is -$16.22 million, with the most recent change of -$1.76 million (-12.17%) on June 30, 2022.
- Over the past year, SYN TTM CFO has dropped by -$5.12 million (-46.08%).
Performance
SYN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
SYN Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.9% | -67.8% | -46.1% |
| 3 y3 years | +25.4% | -46.1% | -16.9% |
| 5 y5 years | +36.2% | +24.1% | -16.9% |
SYN Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | +12.5% | +25.9% | at low |
| 5 y | 5-year | +5.9% | +7.6% | +115.0% | +13.9% | +54.0% | at low |
| alltime | all time | +1091.2% | +201.7% | -191.5% | +255.8% | +3956.0% | +141.0% |
Synthetic Biologics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$4.36 M(-11.1%) | -$16.22 M(+12.2%) |
| Mar 2022 | - | -$4.90 M(+1.9%) | -$14.46 M(+12.2%) |
| Dec 2021 | -$12.89 M(+5.9%) | -$4.81 M(+123.1%) | -$12.89 M(+15.0%) |
| Sep 2021 | - | -$2.16 M(-16.9%) | -$11.21 M(+1.0%) |
| Jun 2021 | - | -$2.60 M(-22.0%) | -$11.11 M(+5.4%) |
| Mar 2021 | - | -$3.33 M(+6.3%) | -$10.54 M(-13.4%) |
| Dec 2020 | -$12.17 M(-12.3%) | -$3.13 M(+52.8%) | -$12.17 M(-3.7%) |
| Sep 2020 | - | -$2.05 M(+1.2%) | -$12.64 M(-7.4%) |
| Jun 2020 | - | -$2.03 M(-59.2%) | -$13.65 M(-6.5%) |
| Mar 2020 | - | -$4.96 M(+37.6%) | -$14.61 M(+5.3%) |
| Dec 2019 | -$13.87 M(-19.7%) | -$3.60 M(+17.7%) | -$13.87 M(+2.3%) |
| Sep 2019 | - | -$3.06 M(+2.7%) | -$13.56 M(-3.8%) |
| Jun 2019 | - | -$2.98 M(-29.4%) | -$14.10 M(-8.6%) |
| Mar 2019 | - | -$4.22 M(+28.4%) | -$15.42 M(-10.7%) |
| Dec 2018 | -$17.28 M(-14.5%) | -$3.29 M(-8.7%) | -$17.28 M(-3.6%) |
| Sep 2018 | - | -$3.60 M(-16.4%) | -$17.92 M(-4.9%) |
| Jun 2018 | - | -$4.31 M(-29.1%) | -$18.84 M(-7.1%) |
| Mar 2018 | - | -$6.08 M(+54.6%) | -$20.27 M(+0.4%) |
| Dec 2017 | -$20.20 M(-27.6%) | -$3.93 M(-13.1%) | -$20.20 M(-24.2%) |
| Sep 2017 | - | -$4.52 M(-21.2%) | -$26.66 M(-5.2%) |
| Jun 2017 | - | -$5.74 M(-4.5%) | -$28.11 M(-0.4%) |
| Mar 2017 | - | -$6.01 M(-42.1%) | -$28.23 M(+1.2%) |
| Dec 2016 | -$27.90 M(-28.3%) | -$10.38 M(+73.6%) | -$27.90 M(-2.1%) |
| Sep 2016 | - | -$5.98 M(+2.1%) | -$28.49 M(-24.5%) |
| Jun 2016 | - | -$5.86 M(+3.3%) | -$37.72 M(-3.6%) |
| Mar 2016 | - | -$5.67 M(-48.3%) | -$39.11 M(+0.6%) |
| Dec 2015 | -$38.89 M(+141.9%) | -$10.97 M(-27.9%) | -$38.89 M(+18.9%) |
| Sep 2015 | - | -$15.21 M(+109.8%) | -$32.70 M(+48.5%) |
| Jun 2015 | - | -$7.25 M(+32.8%) | -$22.02 M(+21.9%) |
| Mar 2015 | - | -$5.46 M(+14.2%) | -$18.07 M(+12.4%) |
| Dec 2014 | -$16.08 M(+108.3%) | -$4.78 M(+5.4%) | -$16.08 M(+14.8%) |
| Sep 2014 | - | -$4.54 M(+37.6%) | -$14.00 M(+25.2%) |
| Jun 2014 | - | -$3.29 M(-5.0%) | -$11.19 M(+17.4%) |
| Mar 2014 | - | -$3.47 M(+28.3%) | -$9.53 M(+23.4%) |
| Dec 2013 | -$7.72 M(-13.4%) | -$2.70 M(+57.2%) | -$7.72 M(-21.1%) |
| Sep 2013 | - | -$1.72 M(+5.3%) | -$9.79 M(+2.9%) |
| Jun 2013 | - | -$1.63 M(-1.7%) | -$9.51 M(+3.8%) |
| Mar 2013 | - | -$1.66 M(-65.2%) | -$9.16 M(+2.8%) |
| Dec 2012 | -$8.92 M(+210.1%) | -$4.77 M(+231.0%) | -$8.92 M(+82.9%) |
| Sep 2012 | - | -$1.44 M(+12.1%) | -$4.87 M(+12.2%) |
| Jun 2012 | - | -$1.29 M(-9.1%) | -$4.34 M(+8.3%) |
| Mar 2012 | - | -$1.42 M(+93.6%) | -$4.01 M(+39.4%) |
| Dec 2011 | -$2.88 M(+151.1%) | -$731.00 K(-19.8%) | -$2.88 M(+2.3%) |
| Sep 2011 | - | -$911.00 K(-4.3%) | -$2.81 M(+0.5%) |
| Jun 2011 | - | -$952.00 K(+238.8%) | -$2.79 M(+368.7%) |
| Mar 2011 | - | -$281.00 K(-57.8%) | -$596.20 K(-47.9%) |
| Dec 2010 | -$1.15 M(-60.8%) | -$665.20 K(-25.8%) | -$1.15 M(-7.3%) |
| Sep 2010 | - | -$895.90 K(-171.9%) | -$1.24 M(+18.4%) |
| Jun 2010 | - | $1.25 M(-250.1%) | -$1.04 M(-67.2%) |
| Mar 2010 | - | -$829.80 K(+9.8%) | -$3.18 M(+9.0%) |
| Dec 2009 | -$2.92 M | -$755.50 K(+7.3%) | -$2.92 M(+1.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | -$704.30 K(-21.0%) | -$2.87 M(-9.9%) |
| Jun 2009 | - | -$891.70 K(+57.2%) | -$3.19 M(-11.6%) |
| Mar 2009 | - | -$567.30 K(-20.3%) | -$3.61 M(-25.7%) |
| Dec 2008 | -$4.85 M(-26.6%) | -$711.50 K(-30.1%) | -$4.85 M(-23.8%) |
| Sep 2008 | - | -$1.02 M(-22.2%) | -$6.37 M(-12.4%) |
| Jun 2008 | - | -$1.31 M(-27.8%) | -$7.27 M(+10.0%) |
| Mar 2008 | - | -$1.81 M(-18.6%) | -$6.60 M(-0.0%) |
| Dec 2007 | -$6.61 M(+179.3%) | -$2.23 M(+16.0%) | -$6.61 M(+32.0%) |
| Sep 2007 | - | -$1.92 M(+197.2%) | -$5.00 M(+33.7%) |
| Jun 2007 | - | -$645.80 K(-64.4%) | -$3.74 M(+2.2%) |
| Mar 2007 | - | -$1.81 M(+190.8%) | -$3.66 M(+54.8%) |
| Dec 2006 | -$2.37 M(+118.6%) | -$624.00 K(-5.0%) | -$2.37 M(+35.8%) |
| Sep 2006 | - | -$657.00 K(+16.2%) | -$1.74 M(+60.6%) |
| Jun 2006 | - | -$565.60 K(+8.9%) | -$1.08 M(+108.9%) |
| Mar 2006 | - | -$519.20 K(+10.0%) | -$519.20 K(-88.5%) |
| Dec 2005 | -$1.08 M(-81.4%) | - | - |
| Mar 2003 | - | -$471.80 K(+27.9%) | -$4.51 M(-22.6%) |
| Dec 2002 | -$5.82 M(-27.8%) | -$368.80 K(-62.4%) | -$5.82 M(-27.8%) |
| Sep 2002 | - | -$980.60 K(-63.5%) | -$8.07 M(-17.1%) |
| Jun 2002 | - | -$2.69 M(+50.5%) | -$9.73 M(+326.0%) |
| Mar 2002 | - | -$1.79 M(-31.7%) | -$2.28 M(-71.7%) |
| Dec 2001 | -$8.07 M(+42.9%) | -$2.62 M(-1.0%) | -$8.07 M(+24.2%) |
| Sep 2001 | - | -$2.64 M(-155.5%) | -$6.49 M(+26.1%) |
| Jun 2001 | - | $4.76 M(-162.9%) | -$5.15 M(-54.8%) |
| Mar 2001 | - | -$7.57 M(+625.8%) | -$11.40 M(+101.8%) |
| Dec 2000 | -$5.65 M(-65.0%) | -$1.04 M(-19.5%) | -$5.65 M(-68.0%) |
| Sep 2000 | - | -$1.30 M(-13.0%) | -$17.65 M(-1.1%) |
| Jun 2000 | - | -$1.49 M(-18.1%) | -$17.85 M(+5.8%) |
| Mar 2000 | - | -$1.82 M(-86.1%) | -$16.87 M(+4.5%) |
| Dec 1999 | -$16.14 M(-13.7%) | -$13.04 M(+769.6%) | -$16.14 M(+324.8%) |
| Sep 1999 | - | -$1.50 M(+195.6%) | -$3.80 M(-11.6%) |
| Jun 1999 | - | -$507.40 K(-53.6%) | -$4.30 M(-77.7%) |
| Mar 1999 | - | -$1.09 M(+56.1%) | -$19.29 M(+3.2%) |
| Dec 1998 | -$18.70 M(+179.1%) | -$700.00 K(-65.0%) | -$18.70 M(0.0%) |
| Sep 1998 | - | -$2.00 M(-87.1%) | -$18.70 M(+3.3%) |
| Jun 1998 | - | -$15.50 M(+3000.0%) | -$18.10 M(+262.0%) |
| Mar 1998 | - | -$500.00 K(-28.6%) | -$5.00 M(-25.4%) |
| Dec 1997 | -$6.70 M(+11.7%) | -$700.00 K(-50.0%) | -$6.70 M(-8.2%) |
| Sep 1997 | - | -$1.40 M(-41.7%) | -$7.30 M(-3.9%) |
| Jun 1997 | - | -$2.40 M(+9.1%) | -$7.60 M(+16.9%) |
| Mar 1997 | - | -$2.20 M(+69.2%) | -$6.50 M(+8.3%) |
| Dec 1996 | -$6.00 M(-20.0%) | -$1.30 M(-23.5%) | -$6.00 M(+27.7%) |
| Sep 1996 | - | -$1.70 M(+30.8%) | -$4.70 M(+56.7%) |
| Jun 1996 | - | -$1.30 M(-23.5%) | -$3.00 M(+76.5%) |
| Mar 1996 | - | -$1.70 M(+325.0%) | -$1.70 M(-51.4%) |
| Dec 1995 | -$7.50 M(+66.7%) | - | - |
| Dec 1994 | -$4.50 M(+28.6%) | - | - |
| Mar 1994 | - | -$400.00 K(-150.0%) | -$3.50 M(0.0%) |
| Dec 1993 | -$3.50 M | $800.00 K(-123.5%) | -$3.50 M(-18.6%) |
| Sep 1993 | - | -$3.40 M(+580.0%) | -$4.30 M(+377.8%) |
| Jun 1993 | - | -$500.00 K(+25.0%) | -$900.00 K(+125.0%) |
| Mar 1993 | - | -$400.00 K | -$400.00 K |
FAQ
- What is Synthetic Biologics annual cash flow from operations?
- What is the all time high annual CFO for Synthetic Biologics?
- What is Synthetic Biologics annual CFO year-on-year change?
- What is Synthetic Biologics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Synthetic Biologics?
- What is Synthetic Biologics quarterly CFO year-on-year change?
- What is Synthetic Biologics TTM cash flow from operations?
- What is the all time high TTM CFO for Synthetic Biologics?
- What is Synthetic Biologics TTM CFO year-on-year change?
What is Synthetic Biologics annual cash flow from operations?
The current annual CFO of SYN is -$12.89 M
What is the all time high annual CFO for Synthetic Biologics?
Synthetic Biologics all-time high annual cash flow from operations is -$1.08 M
What is Synthetic Biologics annual CFO year-on-year change?
Over the past year, SYN annual cash flow from operations has changed by -$722.00 K (-5.93%)
What is Synthetic Biologics quarterly cash flow from operations?
The current quarterly CFO of SYN is -$4.36 M
What is the all time high quarterly CFO for Synthetic Biologics?
Synthetic Biologics all-time high quarterly cash flow from operations is $4.76 M
What is Synthetic Biologics quarterly CFO year-on-year change?
Over the past year, SYN quarterly cash flow from operations has changed by -$1.76 M (-67.80%)
What is Synthetic Biologics TTM cash flow from operations?
The current TTM CFO of SYN is -$16.22 M
What is the all time high TTM CFO for Synthetic Biologics?
Synthetic Biologics all-time high TTM cash flow from operations is -$400.00 K
What is Synthetic Biologics TTM CFO year-on-year change?
Over the past year, SYN TTM cash flow from operations has changed by -$5.12 M (-46.08%)